ATE206414T1 - 5-(aryloxymethyl)oxazoline, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die sie enthalten - Google Patents

5-(aryloxymethyl)oxazoline, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die sie enthalten

Info

Publication number
ATE206414T1
ATE206414T1 AT95402437T AT95402437T ATE206414T1 AT E206414 T1 ATE206414 T1 AT E206414T1 AT 95402437 T AT95402437 T AT 95402437T AT 95402437 T AT95402437 T AT 95402437T AT E206414 T1 ATE206414 T1 AT E206414T1
Authority
AT
Austria
Prior art keywords
alkyl
aryloxymethyl
oxazolines
production
pharmaceutical compositions
Prior art date
Application number
AT95402437T
Other languages
English (en)
Inventor
Christian Jarry
Isabelle Forfar
Jean-Jacques Bosc
Pierre Renard
Elizabeth Scalbert
Beatrice Guardiola
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Application granted granted Critical
Publication of ATE206414T1 publication Critical patent/ATE206414T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT95402437T 1994-11-03 1995-11-02 5-(aryloxymethyl)oxazoline, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die sie enthalten ATE206414T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9413087A FR2726558B1 (fr) 1994-11-03 1994-11-03 Nouvelles 5-(aryloxymethyl) oxazolines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
ATE206414T1 true ATE206414T1 (de) 2001-10-15

Family

ID=9468429

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95402437T ATE206414T1 (de) 1994-11-03 1995-11-02 5-(aryloxymethyl)oxazoline, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die sie enthalten

Country Status (16)

Country Link
US (1) US5686477A (de)
EP (1) EP0710658B1 (de)
JP (1) JP3181211B2 (de)
CN (1) CN1051545C (de)
AT (1) ATE206414T1 (de)
AU (1) AU689320B2 (de)
CA (1) CA2162106C (de)
DE (1) DE69523011T2 (de)
DK (1) DK0710658T3 (de)
ES (1) ES2165410T3 (de)
FI (1) FI955238A7 (de)
FR (1) FR2726558B1 (de)
NO (1) NO305755B1 (de)
NZ (1) NZ280387A (de)
PT (1) PT710658E (de)
ZA (1) ZA959311B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6635668B1 (en) * 1998-07-22 2003-10-21 The University Of North Carolina At Chapel Hill Imidazoline receptor binding compounds
JP2004518797A (ja) * 2001-01-16 2004-06-24 イーストマン ケミカル カンパニー ポリエステル用着色料コンセントレイト
MXPA04001153A (es) * 2001-08-31 2005-02-17 Neurochem Int Ltd Derivados de amidina para tratar la amiloidosis.
EP1517688A2 (de) * 2002-06-19 2005-03-30 Solvay Pharmaceuticals GmbH Arzneimittel zur behandlung von eine inhibition oder aktivitätsverminderung von ph-wert-regulierenden bikarbonat-transporter-proteinen erfordernden erkrangungen
US7262223B2 (en) * 2004-01-23 2007-08-28 Neurochem (International) Limited Amidine derivatives for treating amyloidosis
MX2009008465A (es) * 2007-02-15 2009-08-20 Hoffmann La Roche Nuevas 2-aminooxazolinas como ligandos de taar1.
KR20160042039A (ko) 2013-08-09 2016-04-18 알데릭스, 인코포레이티드 인산염 수송을 억제하기 위한 화합물 및 방법
WO2016105449A1 (en) * 2014-12-22 2016-06-30 Seth Lederman Compounds for use as pain therapeutics

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3052688A (en) * 1962-09-04 Process for the production of
US3110650A (en) * 1961-09-14 1963-11-12 Szabo Hnos Kessler & Cia S R L Synergistic analgesic compositions
US3278382A (en) * 1962-07-23 1966-10-11 Mcneilab Inc 2-amino-5-aryloxazoline compositions and methods of using same
US3161650A (en) * 1963-01-25 1964-12-15 Mcneilab Inc 2-amino-5-aryloxazoline products
US3626067A (en) * 1965-07-01 1971-12-07 Du Pont Substituted oxazolines, useful as pharmaceuticals
US3577428A (en) * 1969-04-14 1971-05-04 Colgate Palmolive Co 2-amino-4-aryloxyalkyl-4-alkyl-2-oxazolines
US3637726A (en) * 1970-04-09 1972-01-25 Dow Chemical Co Substituted-5-((3 4-dihalophenoxy)methyl)-2-oxazoline compounds
US3818028A (en) * 1972-11-01 1974-06-18 Dow Chemical Co Substituted-5-(2,4,6-trihalophenoxy)-methyl)-2-oxazoline compounds
GB8528633D0 (en) * 1985-11-21 1985-12-24 Beecham Group Plc Compounds
FR2645860B1 (fr) * 1989-04-14 1991-07-26 Sarget Lab Nouvelles aryloxymethyl-5 amino-2 oxazolines, syntheses et applications therapeutiques

Also Published As

Publication number Publication date
CN1129697A (zh) 1996-08-28
PT710658E (pt) 2002-02-28
EP0710658A1 (de) 1996-05-08
DK0710658T3 (da) 2001-11-26
ES2165410T3 (es) 2002-03-16
DE69523011T2 (de) 2002-07-11
FR2726558A1 (fr) 1996-05-10
FR2726558B1 (fr) 1996-12-06
NZ280387A (en) 1996-07-26
NO305755B1 (no) 1999-07-19
JP3181211B2 (ja) 2001-07-03
CA2162106C (fr) 2001-04-10
US5686477A (en) 1997-11-11
AU689320B2 (en) 1998-03-26
NO954381D0 (no) 1995-11-02
EP0710658B1 (de) 2001-10-04
JPH08208630A (ja) 1996-08-13
NO954381L (no) 1996-05-06
ZA959311B (en) 1996-05-29
CA2162106A1 (fr) 1996-05-04
FI955238A0 (fi) 1995-11-01
DE69523011D1 (de) 2001-11-08
FI955238L (fi) 1996-05-04
CN1051545C (zh) 2000-04-19
AU3459395A (en) 1996-05-09
FI955238A7 (fi) 1996-05-04

Similar Documents

Publication Publication Date Title
DE69025104D1 (de) Thiazolderivate, Verfahren zur Ihrer Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten
ATE52498T1 (de) Amidderivate.
ID26179A (id) Turunan-turunan benzenasulfonamida dan penggunaannya sebagai obat-obatan
DE69523011D1 (de) 5-(Aryloxymethyl)oxazoline, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen die sie enthalten
AR036176A1 (es) Un derivado de fenil-acetamido-tiazol, un procedimiento para su preparacion, una composicion farmaceutica que lo comprende, un producto o kit que los comprende, y un metodo que utiliza dicho derivado
FI933719A0 (fi) 4-((2-bensotiazolyl)metylamino)-a-((3,4-difluorfenoxi)metyl)-1-piperidinetanol
TW360654B (en) Oxazolidinone derivatives, their preparation and therapeutical use
HU911992D0 (en) 2-(amino-alkyl)-5-(aryl-alkyl)-1,3-dioxanes, and process for the production of the medical preparations containing them
ATE202564T1 (de) Aminomethylheterozyclischederivate, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
SE8904127D0 (sv) New biocyclic amino-substituted compounds
ATE219491T1 (de) Acronycinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
TW429147B (en) Pharmaceutical composition for the treatment of CNS disorders
PT89483A (pt) Processo para a preparacao de derivados da 2-amino acetamida
PT87954A (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados de dioxopiperidina, com efeito antipsicotico
HUT65376A (en) Process for preparing n,n',n-trisubstituted 5-(diamino-methylene)-1,3-dioxane-4,6-diones and pharmaceutical compositions containing them as active ingredient
MY101878A (en) 1,3,4-thiadiazole
ATE73775T1 (de) 2-dithioalkyl-dihydropyridine, verfahren zu ihrer herstellung und pharmazeutische zusammenstellungen, die sie enthalten.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0710658

Country of ref document: EP

REN Ceased due to non-payment of the annual fee